Zusammenfassung
No evidence of relevant clinical antitumor activity against recurrent glioblastoma could be detected. Sagopilone was well tolerated, and moderate-to-severe peripheral neuropathy was observed in despite prolonged administration.
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric
Altmetric